SCHEDULE: Brandes Investment Partners Discloses 14.1% Stake in UTMD

Brandes Investment Partners, L.P. has filed an amended Schedule 13G reporting a 14.12% beneficial ownership stake in Utah Medical Products, Inc.

Summary

• Brandes Investment Partners, L.P. reports beneficial ownership of 449,680 common shares of Utah Medical Products, Inc.
• The reported stake represents 14.12% of the company's outstanding common shares.
• The filing indicates shared voting power over 412,007 shares and shared dispositive power over 449,680 shares.
• The reporting person certifies that the shares were acquired in the ordinary course of business without the intent to change or influence control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral regulatory disclosure confirming existing institutional interest in the company.

Positives

• Significant institutional backing from a major investment firm, signaling long-term confidence in the issuer.

Negatives

• None identified in this regulatory disclosure.

Risks

• Concentrated ownership by institutional investors can lead to increased stock price volatility if the holder decides to divest.

Future Outlook

The filing does not provide forward-looking guidance, as it is a standard disclosure of beneficial ownership.

Industry Context

StockSavvy.ai notes that institutional filings of this nature are standard in the medical device sector, where long-term value investors often maintain significant positions in stable, profitable companies like Utah Medical Products.

Comparison to Industry Standards

• The 14.12% stake is consistent with typical holdings for institutional investment firms specializing in small-cap value equities.
• The filing adheres to standard SEC reporting requirements for institutional investment managers.

Stakeholder Impact

• Shareholders may view the continued 14.12% stake as a sign of stability and institutional support for the current management strategy.

Next Steps

• Continued monitoring of future 13G or 13F filings for changes in position size.

Key Dates

Keywords

Utah Medical Products, UTMD, Brandes Investment Partners, Schedule 13G, Institutional Ownership, Beneficial Ownership